Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: Sensitivity and specificity

Journal of Clinical Neuromuscular Disease

Volumn 10, Issue 4, 2009, Pages 163-169

  De Sousa, Eduardo A ^a   Chin, Russell L ^b   Sander, Howard W ^c   Latov, Norman ^b   Brannagan, Thomas H ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ST VINCENT S HOSPITAL MANHATTAN   (United States)

^d Columbia University Medical Center ^*  (United States)

Author keywords

Aerobic capacity; Exercise intervention; Inclusion body myositis

Indexed keywords

ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; HUMAN; NERVE BIOPSY; NERVE CONDUCTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; AMYOTROPHIC LATERAL SCLEROSIS; CLASSIFICATION; DEMYELINATING DISEASE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYRADICULONEUROPATHY; RETROSPECTIVE STUDY;

AMYOTROPHIC LATERAL SCLEROSIS; DEMYELINATING DISEASES; DIABETIC NEUROPATHIES; ELECTRODIAGNOSIS; HUMANS; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 68549096261     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31819a71e1     Document Type: Article

References (25)

1. Bouchard C, Lacroix C, Plante V, et al. Clinicopath-ologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;52:498-503.
2. Rentzos M, Anyfanti C, Kaponi A, et al. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population. J Clin Neurosci. 2007;14:229-235.
3. Dyck PJ, Lais AC, Ohta M, et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975; 50:621-637.
4. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41: 617-618.
5. Saperstein DS, Katz JS, Amato AA, et al. Clinical spectrum of chronic acquired demyelinating poly-neuropathies. Muscle Nerve. 2001;24:311-324.
6. Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculo-neuropathy. Muscle Nerve. 2002;25:26-30.
7. Magda P, Latov N, Brannagan TH III, et al. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol. 2003; 60:1755-1759.
8. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneurop-athy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst. 2005;10: 220-228.
9. Cocito D, Chiò A, Tavella A, et al. Treatment response and electrophysiological criteria in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2006;13:669-670.
10. Barohn RJ, Kissel JT, Warmolts JR, et al. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol. 1989;46: 878-884.
11. Berger AR, Bradley WG, Brannagan TH, et al. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst. 2003;8:282-284.
12. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48:321-328.
13. Misra UK, Kalita J, Yadav RK. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol. 2007;58:100-105.
14. Katz JS, Saperstein DS, Gronseth G, et al. Distal acquired demyelinating symmetric neuropathy. Neurology. 2000;54:615-620.
15. Lewis RA, Sumner AJ, Brown MJ, et al. Multifocal demyelinating neuropathy with persistent conduction block. Neurology. 1982;32:958-964.
16. Saperstein DS, Amato AA, Wolfe GI, et al. Multifocal acquired demyelinating sensory and motor neurop- athy: the Lewis-Sumner syndrome. Muscle Nerve. 1999;22:560-566.
17. Thaisetthawatkul P, Logigian EL, Herrmann DN. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology. 2002;59:1526-1532.
18. Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve. 1991;14:968-976.
19. Haq RU, Fries TJ, Pendlebury WW, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol. 2000;57:1745-1750.
20. Van den Bergh PY, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004;29: 565-574.
21. Echaniz-Laguna A, Degos B, Mohr M, et al. A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP. Muscle Nerve. 2006;33:356-362.
22. Rajabally YA, Jacob S. Chronic inflammatory de-myelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis. Muscle Nerve. 2008;38:855-860.
23. Wilson JR, Stittsworth JD Jr, Kadir A, et al. Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy. Muscle Nerve. 1998;21:1228-1230.
24. Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes mellitus. Arch Neurol. 2002; 59:758-765.
25. Dyck PJ, Litchy WJ, Daube JR, et al. Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve. 2003;27: 202-210.